알림
뒤로


Key Publications


  • Park JC, Han J, Lee W, Kim J, Lee SE, Lee D, Choi H, Han J, Kim JI, Mook-Jung I. Microglia gravitate toward the amyloid plaques surrounded by externalized phosphatidylserine via TREM2. Nat Neurosci. (Under Review; IF = 28.771)
  • Park JC, Barahona-Torres N, Jang SY, Mok KY, Kim HJ, Han SH, Cho KH, Zhou X, Fu AKY, Ip NY, Seo J, Choi M, Jeong H, Hwang D, Lee DY, Byun MS, Yi D, Han JW, Mook-Jung I, Hardy J. Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology. Adv Sci (Weinh). 2022 Jun 13:e2201212. doi: 10.1002/advs.202201212. (IF = 17.521)
  • Park JC, Lim H, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Female-specific metabolic dysfunction and the relevant genes in the brains of Alzheimer’s disease and its reflection on plasma beta-amyloid 42/40. Exp Mol Med. (In Revision; IF= 12.172)
  • Park JC, Jang SY, Lee D, Lee J, Kang U, Chang H, Kim HJ, Han SH, Seo J, Choi M, Lee DY, Byun MS, Yi D, Cho KH, Mook-Jung I. A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids. Nat Commun. 2021 Jan 12;12(1):280. doi: 10.1038/s41467-020-20440-5. (IF = 17.694)
  • Park JC, Han SH, Lee H, Jeong H, Byun M, Bae J, Kim H, Lee DY, Hwang D, Lee SW, Mook-Jung I. Prognostic plasma protein panel for brain Abeta deposition in Alzheimer’s disease. Prog Neurobiol. 2019 Dec:101690. doi: 10.1016/j.pneurobio.2019.101690. (IF = 10.885)
  • Park JC, Han SH, Yi D, Byun MS, Lee JH, Jang S, Ko K, Jeon SY, Lee YS, Kim YK, Lee DY, Mook-Jung I. Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimers disease. Brain. 2019 Mar 1; 142 (3), 771-786. (IF = 15.255)
  • Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, Cho H, Lee W, Kim DK, Mook-Jung I. Annexin A1 restores Aβ1-42- induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 2017 Feb; 16(1):149-161. (IF = 11.005)


Full-List


2023

  • Park JC, Lim H, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Female-specific metabolic dysfunction and the relevant genes in the brains of Alzheimer’s disease and its reflection on plasma beta-amyloid 42/40. Exp Mol Med. (In Revision; IF= 12.172)
  • Park JC, Han J, Lee W, Kim J, Lee SE, Lee D, Choi H, Han J, Kim JI, Mook-Jung I. Microglia gravitate toward the amyloid plaques surrounded by externalized phosphatidylserine via TREM2. Nat Neurosci. (Under Review; IF = 28.771)

2022

  • Park JC, Mook-Jung I. Toward brain organoid-based precision medicine in neurodegenerative diseases. Organoid. 2022;2:e21. https://doi.org/10.51335/organoid.2022.2.e21 (IF = coming soon)
  • Park JC, Noh J, Jang S, Kim KH, Choi H, Lee D, Kim J, Chung J, Lee DY, Lee Y, Lee H, Yoo DK, Lee AC, Byun MS, Yi D, Han SH, Kwon S, Mook-Jung I. Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease. Cell Rep. 2022 Sep 20;40(12):111391. (IF = 9.995)
  • Park JC, Barahona-Torres N, Jang SY, Mok KY, Kim HJ, Han SH, Cho KH, Zhou X, Fu AKY, Ip NY, Seo J, Choi M, Jeong H, Hwang D, Lee DY, Byun MS, Yi D, Han JW, Mook-Jung I, Hardy J. Multi-Omics-Based Autophagy-Related Untypical Subtypes in Patients with Cerebral Amyloid Pathology. Adv Sci (Weinh). 2022 Jun 13:e2201212. doi: 10.1002/advs.202201212. (IF = 17.521)
  • Kim J, Lee S, Lee J, Park JC, Kim KH, Ko JM, Park SH, Kim SK, Mook-Jung I, Lee JY. Neurotoxicity of phenylalanine on human iPSC-derived cerebral organoids. Mol Genet Metab. 2022 Jun;136(2):132-144. doi: 10.1016/j.ymgme.2022.04.005. Epub 2022 May 2. (IF = 4.204)
  • Lee D, Park JC (Co-first), Jung KS, Kim J, Jang JS, Kwon S, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Application of QPLEXTM biomarkers in cognitively normal individuals across a broad age range and diverse regions with cerebral amyloid deposition. Exp Mol Med. 2022 Jan;54(1):61-71. doi: 10.1038/s12276-021-00719-3. Epub 2022 Jan 20. (IF = 12.172)

2021

  • Kim HJ, Park JC (Co-first), Jung KS, Kim J, Jang JS, Kwon S, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. The clinical use of blood-test factors for Alzheimer's disease: improving the prediction of cerebral amyloid deposition by the QPLEXTM Alz plus assay kit. Exp Mol Med.  2021 Jun 9. doi: 10.1038/s12276-021-00638-3. (IF = 12.172)
  • Park JC, Jang SY, Lee D, Lee J, Kang U, Chang H, Kim HJ, Han SH, Seo J, Choi M, Lee DY, Byun MS, Yi D, Cho KH, Mook-Jung I. A logical network-based drug-screening platform for Alzheimer's disease representing pathological features of human brain organoids. Nat Commun. 2021 Jan 12;12(1):280. doi: 10.1038/s41467-020-20440-5. (IF = 17.694)
  • Park JC, Jung KS, Kim J, Jang JS, Kwon S, Byun MS, Yi D, Byeon G, Jung G, Kim YK, Lee DY, Han SH, Mook-Jung I. Performance of the QPLEX Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition. Alzheimers Res Ther. 2021 Jan 6; 13(1):12. (IF = 8.831)

2020

  • Seo J, Byun MS, Yi D, Lee JH, Jeon SY, Shin SA, Kim YK, Kang KM, Sohn CH, Jung G, Park JC, Han SH, Byun J, Mook-Jung I, Lee DY, Choi M; KBASE Research Group. Genetic associations of in vivo pathology influence Alzheimer’s disease susceptibility. Alzheimers Res Ther. 2020 Nov 19;12(1);156. (IF = 8.831)
  • Yun Y, Lee SY, Choi WH, Park JC, Lee DH, Kim YK, Lee JH, Lee JY, Lee MJ, Kim YH. Proteasome activity in the plasma as a novel biomarker in mild cognitive impairment with Chronic Tinnitus. J Alzheimers Dis.  2020;78(1):195-205. (IF = 4.160)
  • Park JC, Han SH, Mook-Jung I. Peripheral inflammatory biomarkers in Alzheimer’s Disease: A brief review. BMB Rep. 2020 Jan; 53 (1), 10-19. (IF = 5.041)
  • Choi H, Kim H, Yang J, Chae S, Lee W, Chung S, Kim J, Choi H, Song H, Lee CK, Jun JH, Lee YJ, Lee K, Kim S, Sim H, Choi Y, Ryu KH, Park JC, Lee D, Han SH, Hwang D, Kyung J, Mook-Jung I. Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models. Aging Cell. 2020 Jan 19; (1), e13081. (IF = 11.005)

2019

  • Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS, Lee DY, Kim Y, Mook-Jung I. Deep proteome profiling of hippocampus in 5XFAD Mouse model uncovers biological process alterations and a novel biomarker of Alzheimer’s disease. Exp Mol Med. 2019 Nov 15; 51 (11), 136. (IF = 12.172)
  • Park JC, Han SH, Lee H, Jeong H, Byun M, Bae J, Kim H, Lee DY, Hwang D, Lee SW, Mook-Jung I. Prognostic plasma protein panel for brain Abeta deposition in Alzheimer’s disease. Prog Neurobiol. 2019 Dec:101690. doi: 10.1016/j.pneurobio.2019.101690. (IF = 10.885)
  • Park JC, Han SH, Yi D, Byun MS, Lee JH, Jang S, Ko K, Jeon SY, Lee YS, Kim YK, Lee DY, Mook-Jung I. Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimers disease. Brain. 2019 Mar 1; 142 (3), 771-786. (IF = 15.255)
  • Han SH, Park JC (Co-first), Byun MS, Yi D, Lee JH, Lee DY, Mook-Jung I. Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals. Neurobiol Aging. 2019 Jan;73:21-29. (IF = 5.133)

2017

  • Park JC, Han SH, Byun MS, Yi D, Lee JH, Park K, Lee DY, Mook-Jung I. Low Serum Phosphorus Correlates with Cerebral Aβ Deposition in Cognitively Impaired Subjects: Results from the KBASE Study. Front Aging Neurosci. 2017 Nov 6;9:362. (IF = 5.702)
  • Park JC, Han SH, Cho HJ, Byun MS, Yi D, Choe YM, Kang S, Jung ES, Won SJ, Kim EH, Kim YK, Lee DY, Mook-Jung I. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition. Alzheimers Res Ther. 2017 Mar 22;9(1):20. (IF = 8.831)
  • Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, Cho H, Lee W, Kim DK, Mook-Jung I. Annexin A1 restores Aβ1-42- induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell. 2017 Feb; 16(1):149-161. (IF = 11.005)

2016

  • Han SH, Park JC, Mook-Jung I. Amyloid β-interacting partners in Alzheimer’s disease: From accomplices to possible therapeutic targets. Prog Neurobiol. 2016 Feb;137:17-38. (IF = 10.885)

2015

  • Han SH, Park JC, Mook-Jung I. Biomarkers in Alzheimer’s Disease: From Pathogenic Initiation to Downstream Outcomes. In book: Aging Mechanisms. 2015 Jan; 341-354. (IF = n/a)

2014

  • Park R, Kook SY, Park JC, Mook-Jung I. Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NK-kB signaling. Cell Death Dis. 2014 Jun 26;5:e1299. (IF = 9.696)